112 related articles for article (PubMed ID: 15454689)
21. A multimeric form of soluble recombinant sheep LFA-3 (CD58) inhibits human T-cell proliferation.
Yamashita K; Parish CR; Warren HS; Harrison LC
Immunology; 1997 Sep; 92(1):39-44. PubMed ID: 9370922
[TBL] [Abstract][Full Text] [Related]
22. The "erythrocyte receptor" of T-lymphocytes and T11 target structure (T11TS): complementary cell interaction molecules involved in T-cell activation.
Hünig T; Tiefenthaler G; Mitnacht R; Köhler C; Lottspeich F; Meuer S
Behring Inst Mitt; 1987 Jun; (81):31-40. PubMed ID: 2888455
[TBL] [Abstract][Full Text] [Related]
23. T11TS, the cell surface molecule binding to the "erythrocyte receptor" of T lymphocytes: cellular distribution, purification to homogeneity and biochemical properties.
Hünig T; Mitnacht R; Tiefenthaler G; Köhler C; Miyasaka M
Eur J Immunol; 1986 Dec; 16(12):1615-21. PubMed ID: 2880724
[TBL] [Abstract][Full Text] [Related]
24. The other side of the coin: beneficiary effect of 'oxidative burst' upsurge with T11TS facilitates the elimination of glioma cells.
Ghosh A; Mukherjee J; Bhattacharjee M; Sarkar P; Acharya S; Chaudhuri S; Chaudhuri S
Cell Mol Biol (Noisy-le-grand); 2007 May; 53(5):53-62. PubMed ID: 17543233
[TBL] [Abstract][Full Text] [Related]
25. Comparative evaluation of T11 target structure and its deglycosylated derivative nullifies the importance of glycan moieties in immunotherapeutic efficacy.
Chatterjee S; Acharya S; Kumar P; Chatterjee A; Chaudhuri S; Ghosh A; Chaudhuri S
Acta Biochim Biophys Sin (Shanghai); 2012 Mar; 44(3):259-68. PubMed ID: 22257732
[TBL] [Abstract][Full Text] [Related]
26. Purified lymphocyte function-associated antigen-3 and T11 target structure are active in CD2-mediated T cell stimulation.
Tiefenthaler G; Hünig T; Dustin ML; Springer TA; Meuer SC
Eur J Immunol; 1987 Dec; 17(12):1847-50. PubMed ID: 2891540
[TBL] [Abstract][Full Text] [Related]
27. T11TS/S-LFA3 induces apoptosis of the brain tumor cells: a new approach to characterise the apoptosis associated genetic changes by arbitrarily primed-PCR.
Mukherjee J; Ghosh A; Sarkar S; Mazumdar M; Sarkar P; Duttagupta AK; Chaudhuri S
Cancer Lett; 2005 May; 222(1):23-38. PubMed ID: 15837538
[TBL] [Abstract][Full Text] [Related]
28. T11TS inhibits glioma angiogenesis by modulation of MMPs, TIMPs, with related integrin αv and TGF-β1 expressions.
Singh MK; Bhattacharya D; Chaudhuri S; Acharya S; Kumar P; Santra P; Basu AK; Chaudhuri S
Tumour Biol; 2014 Mar; 35(3):2231-46. PubMed ID: 24242015
[TBL] [Abstract][Full Text] [Related]
29. Preclinical Changes in Immunoreactivity and Cellular Architecture during the Progressive Development of Intracranial Neoplasms and an Immunotherapeutic Schedule with a Novel Biological Response Modifier, the T11TS / S-LFA3.
Mukherjee J; Dutta S; Sarkar S; Begum Z; Ghosh A; Chaudhuri S; Chaudhuri S
Asian Pac J Cancer Prev; 2002; 3(4):325-337. PubMed ID: 12716291
[TBL] [Abstract][Full Text] [Related]
30. Serologic cross-reactivity of T11 target structure and lymphocyte function-associated antigen 3. Evidence for structural homology of the sheep and human ligands of CD2.
Tiefenthaler G; Dustin ML; Springer TA; Hünig T
J Immunol; 1987 Oct; 139(8):2696-701. PubMed ID: 2443569
[TBL] [Abstract][Full Text] [Related]
31. Akt Phosphorylation Orchestrates T11TS Mediated Cell Cycle Arrest in Glioma Cells.
Acharya S; Chatterjee S; Chaudhuri S; Singh MK; Bhattacharya D; Bhattacharjee M; Ghosh A; Chaudhuri S
Cancer Invest; 2021 Nov; 39(10):854-870. PubMed ID: 34569407
[TBL] [Abstract][Full Text] [Related]
32. Evidence that activation of human T cells by porcine endothelium involves direct recognition of porcine SLA and costimulation by porcine ligands for LFA-1 and CD2.
Rollins SA; Kennedy SP; Chodera AJ; Elliott EA; Zavoico GB; Matis LA
Transplantation; 1994 Jun; 57(12):1709-16. PubMed ID: 7912457
[TBL] [Abstract][Full Text] [Related]
33. Anti-CD2 monoclonal antibody-induced receptor changes: down modulation of cell surface CD2.
Lin J; Yon RW; Chavin KD; Qin L; Woodward J; Ding Y; Yagita H; Bromberg JS
Transplantation; 1995 Apr; 59(8):1162-71. PubMed ID: 7537394
[TBL] [Abstract][Full Text] [Related]
34. Impaired capacity for upregulation of MHC class II in tumor-associated microglia.
Schartner JM; Hagar AR; Van Handel M; Zhang L; Nadkarni N; Badie B
Glia; 2005 Sep; 51(4):279-85. PubMed ID: 15818597
[TBL] [Abstract][Full Text] [Related]
35. Immunomodulatory role of TIITS in respect to cytotoxic lymphocytes in four grades of human glioma.
Kumar P; Acharya S; Chatterjee S; Kumari A; Chaudhuri S; Singh MK; Ghosh SN; Chaudhuri S
Cell Immunol; 2012; 276(1-2):176-86. PubMed ID: 22704241
[TBL] [Abstract][Full Text] [Related]
36. Restricted expression of CD2 among subsets of sheep thymocytes and T lymphocytes.
Giegerich GW; Hein WR; Miyasaka M; Tiefenthaler G; Hünig T
Immunology; 1989 Mar; 66(3):354-61. PubMed ID: 2564842
[TBL] [Abstract][Full Text] [Related]
37. The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses.
Hussain SF; Yang D; Suki D; Aldape K; Grimm E; Heimberger AB
Neuro Oncol; 2006 Jul; 8(3):261-79. PubMed ID: 16775224
[TBL] [Abstract][Full Text] [Related]
38. Expression of glucose transporter 5 by microglia in human gliomas.
Sasaki A; Yamaguchi H; Horikoshi Y; Tanaka G; Nakazato Y
Neuropathol Appl Neurobiol; 2004 Oct; 30(5):447-55. PubMed ID: 15488021
[TBL] [Abstract][Full Text] [Related]
39. Alternative pathway activation of T cells by binding of CD2 to its cell-surface ligand.
Hünig T; Tiefenthaler G; Meyer zum Büschenfelde KH; Meuer SC
Nature; 1987 Mar 19-25; 326(6110):298-301. PubMed ID: 3102975
[TBL] [Abstract][Full Text] [Related]
40. Rosette formation between human lymphocytes and sheep erythrocytes. Inhibition of rosette formation by specific glycopeptides.
Boldt DH; Armstrong JP
J Clin Invest; 1976 Apr; 57(4):1068-78. PubMed ID: 59739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
